MIM
RAIN

Monashee Investment Management’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Monashee Investment Management’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,159
Closed -$272K – 92
2023
Q1 		$272K Sell
31,159
-283,012
-90% -$2.62M 0.08% 53
2022
Q4 		$2.51M Buy
+314,171
New +$1.97M 1.08% 27
2021
Q3 		– Sell
-20,000
Closed -$311K – 406
2021
Q2 		$311K Buy
+20,000
New +$350K 0.04% 254

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Monashee Investment Management's RAIN Position: Q2 2023 in Review

Monashee Investment Management sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 31,159 shares — an estimated $272K sold.

Monashee Investment Management first reported a position in RAIN in Q2 2021 and held it in 3 quarters. The position peaked at $2.51M in Q4 2022. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • Monashee Investment Management reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Monashee Investment Management sold 31,159 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $272K.
  • Monashee Investment Management first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Monashee Investment Management's Rain Oncology Inc. Common Stock position peaked at $2.51M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on Monashee Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.